Table 1. Histopathology of Tg26 and Tg26 x APOL1 dual transgenic mice.
Tg26 (n = 21) |
P | Tg26+G0 (n = 21) |
P | Tg26+G2 (n = 18) | P | |
---|---|---|---|---|---|---|
# scored glomeruli per animal, mean | 201 | 230 | 210 | |||
Segmental sclerotic, % of total glomeruli | 9.9% | ref | 6.6% | NS | 10.9% | NS |
Global sclerotic, % of total glomeruli | 3.7% | ref | 3.8% | NS | 5.2% | NS |
Segmental collapse, % of total glomeruli | 0% | ref | 0% | NS | 0% | NS |
Global collapse, % of total glomeruli | 0% | ref | 0.4% | NS | 0% | NS |
Glomerular hyperplasia, any | 6.0% | ref | 6.0% | NS | 1.5% | NS |
Podocyte hypertrophy, any | 10.0% | ref | 16.0% * | NS | 1.5% | NS |
Tubular microcysts, mean±SD scored on 0–4 scale |
0.88 ± 1.27 | ref | 0.90 ± 1.47 | NS | 0.89 ± 1.33 | NS |
Tubular atrophy, mean±SD scored on 0–4 scale |
0.07 ± 0.24 | ref | 0.05 ± 0.22 | NS | 0 ± 0 | NS |
Interstitial fibrosis, mean±SD scored on 0–4 scale |
0.05 ± 0.22 | ref | 0.20 ± 0.52 | NS | 0.17 ± 0.51 | NS |
Interstitial inflammation, mean±SD scored on 0–4 scale |
0.93 ± 1.29 | ref | 1.26 ± 1.66 | NS | 1.08 ± 1.41 | NS |
NS, not significant compared to Tg26. * P = 0.03 compared to Tg26+G2.